Literature DB >> 21914026

A novel finding of the atrial substrate properties and long-term results of catheter ablation in chronic atrial fibrillation patients with left atrial spontaneous echo contrast.

Beny Hartono1, Li-Wei Lo, Chen-Chuan Cheng, Yenn-Jiang Lin, Shih-Lin Chang, Yu-Feng Hu, Kazuyoshi Suenari, Cheng Hung Li, Tze-Fan Chao, Shuen-Hsin Liu, Ya-Lei Niu, Hung-Yu Chang, Kibos Ambrose, Wen-Chung Yu, Tsui-Lieh Hsu, Shih-Ann Chen.   

Abstract

BACKGROUND: The atrial substrate in chronic atrial fibrillation (AF) patients with a left atrial spontaneous echo contrast (LASEC) has not been previously reported. The aim of this study was to investigate the atrial substrate properties and long-term follow-up results in the patients who received catheter ablation of chronic AF.
METHODS: Of 36 consecutive patients with chronic AF who received a stepwise ablation approach, 18 patients with an LASEC (group I) were compared with 18 age-gender-left atrial volume matched patients without an LASEC (group II). The atrial substrate properties including the weighted peak-to-peak voltage, total activation time during sinus rhythm (SR), dominant frequency (DF), and complex fractionated electrograms (CFEs) during AF in the bi-atria were evaluated. RESULT: The left atrial weighted bipolar peak-to-peak voltage (1.0 ± 0.6 vs 1.6 ± 0.7 mV, P = 0.04), total activation time (119 ± 20 vs 103 ± 13 ms, P < 0.001) and DF (7.3 ± 1.3 vs 6.6 ± 0.7 Hz, P < 0.001) differed between group I and group II, respectively. Those parameters did not differ in the right atrium. The bi-atrial CFEs (left atrium: 89 ± 24 vs 92 ± 25, P = 0.8; right atrium: 92 ± 25 vs 102 ± 3, P = 0.9) did not differ between group I and group II, respectively. After a mean follow-up of 30 ± 13 month, there were significant differences in the antiarrhythmic drugs (1.1 ± 0.3 vs 0.7 ± 0.5, P = 0.02) needed after ablation, and recurrence as persistent AF (92% vs 50%, P = 0.03) between group I and group II, respectively. After multiple procedures, there were more group II patients that remained in SR, when compared with group I (78% vs 44%, P = 0.04).
CONCLUSION: There was a poorer atrial substrate, lesser SR maintenance after catheter ablation and need for more antiarrhythmic drugs in the chronic AF patients with an LASEC when compared with those without an LASEC.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21914026     DOI: 10.1111/j.1540-8167.2011.02170.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

Review 1.  Chemical transmitter systems in the brain.

Authors:  C C Shute
Journal:  Mod Trends Neurol       Date:  1975

2.  Fibrillatory wave amplitude on transesophageal ECG as a marker of left atrial low-voltage areas in patients with persistent atrial fibrillation.

Authors:  Ran Yin; Yongnan Fu; Zhongming Yang; Bingong Li; Jintian Pen; Zeqi Zheng
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-01-16       Impact factor: 1.468

Review 3.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

Review 4.  Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.

Authors:  Faisal F Syed; Hakan Oral
Journal:  J Atr Fibrillation       Date:  2015-12-31

5.  Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation.

Authors:  Yang Liu; Xiao-Hui Niu; Xiaomeng Yin; Yue-Jian Liu; Chao Han; Jie Yang; Xin Huang; Xiaohong Yu; Lianjun Gao; Yan-Zong Yang; Yun-Long Xia; Hui-Hua Li
Journal:  J Am Heart Assoc       Date:  2018-03-13       Impact factor: 5.501

6.  Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Authors:  Ruopeng Tan; Haixu Yu; Xu Han; Yang Liu; Xiaolei Yang; Yun-Long Xia; Xiaomeng Yin
Journal:  Front Cardiovasc Med       Date:  2021-06-17

7.  Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation.

Authors:  Tze-Fan Chao; Chung-Lieh Hung; Hsuan-Ming Tsao; Yenn-Jiang Lin; Chun-Ho Yun; Yau-Huei Lai; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Hung-Yu Chang; Jen-Yuan Kuo; Hung-I Yeh; Tsu-Juey Wu; Ming-Hsiung Hsieh; Wen-Chung Yu; Shih-Ann Chen
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

8.  Role of serum TGF-β1 level in atrial fibrosis and outcome after catheter ablation for paroxysmal atrial fibrillation.

Authors:  Ye Tian; Yubin Wang; Weijie Chen; Yuehui Yin; Mu Qin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.